bioRxiv ScienceSearch

bioRxiv · 10.1101/344390

Resting state fMRI based target selection for personalized rTMS: stimulation over the left DLPFC temporarily alters the default mode network in healthy subjects

Abstract

High frequency repetitive TMS (HF-rTMS) to the left dorsolateral prefrontal cortex (DLPFC) is an approved option for the treatment of depression, but there is also much variability in the resulting antidepressant response. This variability is believed to arise from various factors, an important one of which being the method by which rTMS is targeted to the optimal stimulation site in the left DLPFC. To more accurately target HF-rTMS at left DLPFC, we present a new method for target selection based on individual RS-fMRI data. We show in 23 healthy subjects that the new proposed method of target selection is reproducible and yields left DLPFC targets whose functional connectivity correlates more negatively with subgenual anterior cingulate cortex (sgACC) than targets based on standard MNI coordinates. Since previous work has highlighted higher negative connectivity with the sgACC as an important feature of targets for higher antidepressant effect of HF-rTMS, the targets selected by the new method can be expected to lead to a higher therapeutic response. Additionally, the mechanism of action of an entire single session of HF-rTMS (3000 pulses) in healthy subjects has not been reported. We show significant decreases in functional connectivity of the default mode network in sgACC and ventral striatum (vStr) regions, peaking at 27-32 minutes after stimulation. Also, we report a negative correlation between the magnitude of this decrease in the right sgACC and the harm avoidance domain measure from the Temperament and Character Inventory (TCI). This finding points towards the possibility of using the harm avoidance measure as a predictor of HF-rTMS response. In addition, the decreased functional connectivity of the default mode network in right nucleus accumbens (NAcc) correlates with a short-term decrease in self-rated negative emotions from the Positive and Negative Affect Schedule (PANAS) i.e. the lower the functional connectivity of right NAcc with the default mode network, the lower the reported perception of negative mood by the subjects. This suggests a mechanism by which changes induced by rTMS influence the perception of negative mood in recipients.

Source connections

Explore related subjects

Keep this discovery

BibTeXRIS

Singh, A., Erwin-Grabner, T., Sutcliffe, G., Antal, A., Paulus, W., Goya-Maldonado, R.. 2018-06-12. Resting state fMRI based target selection for personalized rTMS: stimulation over the left DLPFC temporarily alters the default mode network in healthy subjects. https://doi.org/10.1101/344390

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience